Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases,
which are increasing in prevalence. However, the failure of conventional lipid-lowering …

Role of serum amyloid A in atherosclerosis : Current Opinion in Lipidology Role of serum amyloid
A in atherosclerosis : Current Opinion in Lipidology Log in or Register Subscribe to …

Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the leading cause of
cardiac disorders and stroke. The onset and progression of these diseases are linked with …

High-density lipoprotein (HDL) metabolism is regulated by complex interplay between the
scavenger receptor group B type 1 (SR-BI) and multiple signaling molecules in the liver …

Plaque rupture and thrombosis are the most important clinical complications in the
pathogenesis of stroke, coronary arteries, and peripheral vascular diseases. The …

Background and aim Metabolic syndrome (MetS) increases the risk of atherosclerosis and
diabetes, but there are no approved predictive markers. This study assessed the role of …

The scavenger receptor class B type I (SR-BI) is a versatile HDL receptor protein. It is highly
expressed in liver and steroidogenic tissues. SR-BI regulates selective uptake of cholesterol …

The anti-atherogenic properties of high-density lipoproteins (HDL) have been explained
mainly by reverse cholesterol transport (RCT) from peripheral tissues to the liver. The RCT …

The anti-oxidative and anti-inflammatory properties of high-density lipoprotein (HDL) are
thought to be mediated by paraoxonase 1 (PON1), a calcium-dependent hydrolytic enzyme …

Background Inflammation participates pivotally in the pathogenesis of atherosclerosis.
Apolipoprotein M (apoM) is a high-density lipoprotein (HDL)-associated plasma protein that …